Vistagen Therapeutics, Inc.
VTGN—
Vistagen Therapeutics, Inc.VTGN$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-1.67
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$486,000
Net income
$-51.42M
Net margin
-10579.8%
Gross margin
—
Dividends & financials
Vistagen Therapeutics, Inc. (VTGN) reported revenue of $486,000 and net income of $-51.42M, or $-1.67 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.